GlassScriptPhysician profile
William B Wheatley
NPI 1740288224
$6,338.87
in general payments reported to CMS, 2019-2025
15 companies · $31.47 in 2025
The $31.47 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,988 · 2020: $994 · 2021: $1,628 · 2022: $23.54 · 2023: $46.87 · 2024: $1,628 · 2025: $31.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,448 · Food and Beverage: $258.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,448.05 |
| Food and Beverage | $257.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrosurface Incorporated | $1,742.64 | 2019 | |
| Zimmer Biomet Holdings, INC. | $1,686.41 | 2019-2024 | Comprehensive Shoulder System |
| Arthrex, INC. | $1,520.00 | 2021-2024 | |
| Tricoast Surgical Solutions LLC | $942.39 | 2024 | |
| Avanos Medical | $127.76 | 2020-2021 | |
| Baudax Bio INC. | $64.38 | 2020-2021 | |
| Pacira Therapeutics, INC. | $49.12 | 2019 | |
| Smith+Nephew, INC. | $46.87 | 2023 | Stravix Pl, Oasis, Grafix |
| Fidia Pharma USA INC. | $44.79 | 2019 | |
| Baxter Healthcare | $31.47 | 2025 | Tisseel |
| Medtronic, INC. | $23.54 | 2022 | |
| Ferring Pharmaceuticals INC. | $16.70 | 2019 | |
| Depuy Synthes Sales INC. | $15.17 | 2024 | Orthovisc, Monovisc |
| Sanofi-Aventis U.S. LLC | $14.19 | 2019 | |
| Endo Pharmaceuticals INC. | $13.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Wheatley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.